Excision of HIV-1 DNA by Gene Editing: A Proof-Of-Concept in Vivo Study

Gene Therapy- United Kingdom

doi 10.1038/gt.2016.45

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Proof-Of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency

Scientific Reports
Multidisciplinary
2017English

Add-On Pyridostigmine Enhances CD4+ T-Cell Recovery in HIV-1-Infected Immunological Non-Responders: A Proof-Of-Concept Study

Frontiers in Immunology
AllergyImmunology
2017English

In Vivo Assessment of Neuroinflammation in Progressive Multiple Sclerosis: A Proof of Concept Study With [18F]DPA714 PET

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2018English

A RNAi-based Therapeutic Proof of Concept Targets Salmonid Whirling Disease in Vivo

PLoS ONE
Multidisciplinary
2017English

In Vivo Proof of Concept of Adoptive Immunotherapy for Hepatocellular Carcinoma Using Allogeneic Suicide Gene-Modified Killer Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

A Proof of Concept Study of Infliximab for the Treatment of HTLV-1-associated Myelopathy

Retrovirology
VirologyInfectious Diseases
2014English

Editing Transgenic DNA Components by Inducible Gene Replacement in Drosophila Melanogaster

Genetics
Genetics
2016English

Fluorescence-Guided Stereotactic Biopsy: A Proof-Of-Concept Study

Journal of Neurosurgery
SurgeryNeurology
2020English

PTD-Modified ATTEMPTS for Enhanced Toxin-Based Cancer Therapy: An in Vivo Proof-Of-Concept Study

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy